Browse by author
Lookup NU author(s): Dr Keng Wooi NgORCiD, Andrea Williams, Dr Wing Man LauORCiD
This is the authors' accepted manuscript of a conference proceedings (inc. abstract) that has been published in its final definitive form by Academy of Pharmaceutical Sciences, 2019.
For re-use rights please refer to the publisher's terms and conditions.
Hyperbaric oxygen (HBO) therapy (i.e. the inspiration of pure oxygen typically at 2–3ATA) is used to treat certain types of chronic wounds [1]. The promotion of wound healing by HBO is largely attributed to increased oxygen solubility in the plasma under heightened pressure according to Henry’s Law, leading to enhanced tissue oxygenation. There has been little literature on the potential cellular effects of hyperbaric pressure alone. Here, we have decoupled hyperbaric pressurisation and hyperoxygenation to ascertain if they might exert independent effects on the growth behaviour of human keratinocytes in wound re-epithelialisation. Human keratinocytes (HaCaT) were cultured under normal atmospheric pressure (1ATA) and 5% CO2/95% air. HBO, hyperbaric air (HBA) or normobaric oxygen (NBO) were administered once daily for 2 h over up to 48 h (Table 1). Oxygen concentration in the culture medium was determined using a Jenway 970 dissolved oxygen meter. Cell migration and proliferation were assessed using the scratch assay and tetrazolium (MTT) assay, respectively. Cellular expressions of E-cadherin (cell adhesion marker), proliferating cell nuclear antigen (PCNA, cell proliferation marker) and involucrin (cell differentiation marker) were determined by Western blotting. Interleukin (IL)-6 and IL-8 release into the cell culture supernatant was quantified using enzyme-linked immunosorbent assays (ELISA). Maximum dissolved oxygen concentrations were 9.1 mg/mL (HBO), 6.5 mg/mL (NBO) and 1.9 mg/mL (HBA). HBO and NBO were associated with enhanced cell migration and reduced cell proliferation, with simultaneous downregulation of E-cadherin and PCNA (Figure 1). Cell differentiation was unaltered by any treatment. IL-6 release was reduced only with NBO, whilst IL-8 release was reduced only with HBO. Thus, the effects of HBO and NBO on HaCaT cell migration and proliferation are attributable to hyperoxygenation and not hyperbaric pressurisation. However, hyperbaric pressurisation may synergise with hyperoxygenation to exert an immunomodulatory effect on the cells. HBO and NBO exert similar effects on keratinocyte migration and proliferation. Further research should establish whether NBO can be a viable alternative treatment, to potentially avoid pressure-related adverse effects associated with HBO, such as barotrauma.
Author(s): Ng KW, Obeid KA, Williams AC, Lau WM
Publication type: Conference Proceedings (inc. Abstract)
Publication status: Published
Conference Name: 10th APS International PharmSci Conference
Year of Conference: 2019
Online publication date: 11/09/2019
Acceptance date: 08/07/2019
Date deposited: 17/12/2019
Publisher: Academy of Pharmaceutical Sciences
URL: https://www.apsgb.co.uk/event/pharmsci-2019/
